Apimeds Pharmaceuticals US, Inc.
APUSDrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
histamine
Osteoarthritis of the Knee
honeybee venom (Apitoxin (Korea) Apitox (USA))
Osteoarthritis of the Knee
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
histamine | Phase 3 | Osteoarthritis of the Knee | - | - |
honeybee venom (Apitoxin (Korea) Apitox (USA)) | Phase 2 | Osteoarthritis of the Knee | - | - |
Frequently asked questions
What is in Apimeds Pharmaceuticals US, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Apimeds Pharmaceuticals US, Inc.'s (APUS) pipeline across Phase 3, Phase 2. Its lead program is histamine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Apimeds Pharmaceuticals US, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Apimeds Pharmaceuticals US, Inc. (APUS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track APUS biotech catalysts?→
Add APUS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Apimeds Pharmaceuticals US, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.